Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Prescription Dermatological Medications Market Insights, Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Prescription Dermatological Medications Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Prescription Dermatological Medications Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Prescription Dermatological Medications Market Size Growth Rate by Type
    • 1.4.2 Oral
    • 1.4.3 Topical
  • 1.5 Market by Application
    • 1.5.1 Global Prescription Dermatological Medications Market Size Growth Rate by Application
    • 1.5.2 Hospital Pharmacies
    • 1.5.3 Online Pharmacies
    • 1.5.4 Retail Pharmacies
  • 1.6 Coronavirus Disease 2019 (Covid-19): Prescription Dermatological Medications Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Prescription Dermatological Medications Industry
      • 1.6.1.1 Prescription Dermatological Medications Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Prescription Dermatological Medications Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Prescription Dermatological Medications Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Prescription Dermatological Medications Market Size Estimates and Forecasts
    • 2.1.1 Global Prescription Dermatological Medications Revenue 2015-2026
    • 2.1.2 Global Prescription Dermatological Medications Sales 2015-2026
  • 2.2 Prescription Dermatological Medications Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Prescription Dermatological Medications Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Prescription Dermatological Medications Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Prescription Dermatological Medications Competitor Landscape by Players

  • 3.1 Prescription Dermatological Medications Sales by Manufacturers
    • 3.1.1 Prescription Dermatological Medications Sales by Manufacturers (2015-2020)
    • 3.1.2 Prescription Dermatological Medications Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Prescription Dermatological Medications Revenue by Manufacturers
    • 3.2.1 Prescription Dermatological Medications Revenue by Manufacturers (2015-2020)
    • 3.2.2 Prescription Dermatological Medications Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Prescription Dermatological Medications Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Prescription Dermatological Medications Revenue in 2019
    • 3.2.5 Global Prescription Dermatological Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Prescription Dermatological Medications Price by Manufacturers
  • 3.4 Prescription Dermatological Medications Manufacturing Base Distribution, Product Types
    • 3.4.1 Prescription Dermatological Medications Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Prescription Dermatological Medications Product Type
    • 3.4.3 Date of International Manufacturers Enter into Prescription Dermatological Medications Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Prescription Dermatological Medications Market Size by Type (2015-2020)
    • 4.1.1 Global Prescription Dermatological Medications Sales by Type (2015-2020)
    • 4.1.2 Global Prescription Dermatological Medications Revenue by Type (2015-2020)
    • 4.1.3 Prescription Dermatological Medications Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Prescription Dermatological Medications Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Prescription Dermatological Medications Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Prescription Dermatological Medications Revenue Forecast by Type (2021-2026)
    • 4.2.3 Prescription Dermatological Medications Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Prescription Dermatological Medications Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Prescription Dermatological Medications Market Size by Application (2015-2020)
    • 5.1.1 Global Prescription Dermatological Medications Sales by Application (2015-2020)
    • 5.1.2 Global Prescription Dermatological Medications Revenue by Application (2015-2020)
    • 5.1.3 Prescription Dermatological Medications Price by Application (2015-2020)
  • 5.2 Prescription Dermatological Medications Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Prescription Dermatological Medications Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Prescription Dermatological Medications Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Prescription Dermatological Medications Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Prescription Dermatological Medications by Country
    • 6.1.1 North America Prescription Dermatological Medications Sales by Country
    • 6.1.2 North America Prescription Dermatological Medications Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Prescription Dermatological Medications Market Facts & Figures by Type
  • 6.3 North America Prescription Dermatological Medications Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Prescription Dermatological Medications by Country
    • 7.1.1 Europe Prescription Dermatological Medications Sales by Country
    • 7.1.2 Europe Prescription Dermatological Medications Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Prescription Dermatological Medications Market Facts & Figures by Type
  • 7.3 Europe Prescription Dermatological Medications Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Prescription Dermatological Medications by Region
    • 8.1.1 Asia Pacific Prescription Dermatological Medications Sales by Region
    • 8.1.2 Asia Pacific Prescription Dermatological Medications Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Prescription Dermatological Medications Market Facts & Figures by Type
  • 8.3 Asia Pacific Prescription Dermatological Medications Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Prescription Dermatological Medications by Country
    • 9.1.1 Latin America Prescription Dermatological Medications Sales by Country
    • 9.1.2 Latin America Prescription Dermatological Medications Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Prescription Dermatological Medications Market Facts & Figures by Type
  • 9.3 Central & South America Prescription Dermatological Medications Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Prescription Dermatological Medications by Country
    • 10.1.1 Middle East and Africa Prescription Dermatological Medications Sales by Country
    • 10.1.2 Middle East and Africa Prescription Dermatological Medications Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Prescription Dermatological Medications Market Facts & Figures by Type
  • 10.3 Middle East and Africa Prescription Dermatological Medications Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Mylan Pharmaceuticals
    • 11.1.1 Mylan Pharmaceuticals Corporation Information
    • 11.1.2 Mylan Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.1.3 Mylan Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Mylan Pharmaceuticals Prescription Dermatological Medications Products Offered
    • 11.1.5 Mylan Pharmaceuticals Recent Development
  • 11.2 Pfizer
    • 11.2.1 Pfizer Corporation Information
    • 11.2.2 Pfizer Description, Business Overview and Total Revenue
    • 11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Pfizer Prescription Dermatological Medications Products Offered
    • 11.2.5 Pfizer Recent Development
  • 11.3 Almirall
    • 11.3.1 Almirall Corporation Information
    • 11.3.2 Almirall Description, Business Overview and Total Revenue
    • 11.3.3 Almirall Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Almirall Prescription Dermatological Medications Products Offered
    • 11.3.5 Almirall Recent Development
  • 11.4 Bausch Health
    • 11.4.1 Bausch Health Corporation Information
    • 11.4.2 Bausch Health Description, Business Overview and Total Revenue
    • 11.4.3 Bausch Health Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Bausch Health Prescription Dermatological Medications Products Offered
    • 11.4.5 Bausch Health Recent Development
  • 11.5 Barrier Therapeutics
    • 11.5.1 Barrier Therapeutics Corporation Information
    • 11.5.2 Barrier Therapeutics Description, Business Overview and Total Revenue
    • 11.5.3 Barrier Therapeutics Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Barrier Therapeutics Prescription Dermatological Medications Products Offered
    • 11.5.5 Barrier Therapeutics Recent Development
  • 11.6 PharmaDerm
    • 11.6.1 PharmaDerm Corporation Information
    • 11.6.2 PharmaDerm Description, Business Overview and Total Revenue
    • 11.6.3 PharmaDerm Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 PharmaDerm Prescription Dermatological Medications Products Offered
    • 11.6.5 PharmaDerm Recent Development
  • 11.7 Bristol-Myers Squibb
    • 11.7.1 Bristol-Myers Squibb Corporation Information
    • 11.7.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
    • 11.7.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Bristol-Myers Squibb Prescription Dermatological Medications Products Offered
    • 11.7.5 Bristol-Myers Squibb Recent Development
  • 11.8 Galderma
    • 11.8.1 Galderma Corporation Information
    • 11.8.2 Galderma Description, Business Overview and Total Revenue
    • 11.8.3 Galderma Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Galderma Prescription Dermatological Medications Products Offered
    • 11.8.5 Galderma Recent Development
  • 11.9 Novartis
    • 11.9.1 Novartis Corporation Information
    • 11.9.2 Novartis Description, Business Overview and Total Revenue
    • 11.9.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Novartis Prescription Dermatological Medications Products Offered
    • 11.9.5 Novartis Recent Development
  • 11.1 Mylan Pharmaceuticals
    • 11.1.1 Mylan Pharmaceuticals Corporation Information
    • 11.1.2 Mylan Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.1.3 Mylan Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Mylan Pharmaceuticals Prescription Dermatological Medications Products Offered
    • 11.1.5 Mylan Pharmaceuticals Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Prescription Dermatological Medications Market Estimates and Projections by Region
    • 12.1.1 Global Prescription Dermatological Medications Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Prescription Dermatological Medications Revenue Forecast by Regions 2021-2026
  • 12.2 North America Prescription Dermatological Medications Market Size Forecast (2021-2026)
    • 12.2.1 North America: Prescription Dermatological Medications Sales Forecast (2021-2026)
    • 12.2.2 North America: Prescription Dermatological Medications Revenue Forecast (2021-2026)
    • 12.2.3 North America: Prescription Dermatological Medications Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Prescription Dermatological Medications Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Prescription Dermatological Medications Sales Forecast (2021-2026)
    • 12.3.2 Europe: Prescription Dermatological Medications Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Prescription Dermatological Medications Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Prescription Dermatological Medications Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Prescription Dermatological Medications Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Prescription Dermatological Medications Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Prescription Dermatological Medications Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Prescription Dermatological Medications Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Prescription Dermatological Medications Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Prescription Dermatological Medications Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Prescription Dermatological Medications Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Prescription Dermatological Medications Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Prescription Dermatological Medications Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Prescription Dermatological Medications Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Prescription Dermatological Medications Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Prescription Dermatological Medications Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Prescription Dermatological Medications Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Dermatology diseases includes common skin rashes to severe skin infections, which occurs due to range of things, such as infections, heat, allergens, system disorders and medications.
    Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Prescription Dermatological Medications market in 2020.
    COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
    The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
    This report also analyses the impact of Coronavirus COVID-19 on the Prescription Dermatological Medications industry.
    Based on our recent survey, we have several different scenarios about the Prescription Dermatological Medications YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Prescription Dermatological Medications will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
    With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Prescription Dermatological Medications market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Prescription Dermatological Medications market in terms of both revenue and volume.
    Players, stakeholders, and other participants in the global Prescription Dermatological Medications market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
    Sales and Pricing Analyses
    Readers are provided with deeper sales analysis and pricing analysis for the global Prescription Dermatological Medications market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
    In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
    Regional and Country-level Analysis
    The report offers an exhaustive geographical analysis of the global Prescription Dermatological Medications market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
    Competition Analysis
    In the competitive analysis section of the report, leading as well as prominent players of the global Prescription Dermatological Medications market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Prescription Dermatological Medications market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Prescription Dermatological Medications market.
    The following manufacturers are covered in this report:
    Mylan Pharmaceuticals
    Pfizer
    Almirall
    Bausch Health
    Barrier Therapeutics
    PharmaDerm
    Bristol-Myers Squibb
    Galderma
    Novartis
    Prescription Dermatological Medications Breakdown Data by Type
    Oral
    Topical
    Prescription Dermatological Medications Breakdown Data by Application
    Hospital Pharmacies
    Online Pharmacies
    Retail Pharmacies

    Buy now